Publishing research using ab1440? Please let us know so that we can cite the reference in this datasheet.

ab1440 has been referenced in 14 publications.

  • Yano M  et al. Association of histone deacetylase expression with histology and prognosis of ovarian cancer. Oncol Lett 15:3524-3531 (2018). PubMed: 29456726
  • Li C  et al. The immunohistochemical expression and potential prognostic value of HDAC6 and AR in invasive breast cancer. Hum Pathol 75:16-25 (2018). PubMed: 29180246
  • Zan J  et al. Rabies Virus Infection Induces Microtubule Depolymerization to Facilitate Viral RNA Synthesis by Upregulating HDAC6. Front Cell Infect Microbiol 7:146 (2017). WB ; Mouse . PubMed: 28491824
  • Stoney PN  et al. A seasonal switch in histone deacetylase gene expression in the hypothalamus and their capacity to modulate nuclear signaling pathways. Brain Behav Immun 61:340-352 (2017). PubMed: 27993690
  • Wei J  et al. Histone Modification of Nedd4 Ubiquitin Ligase Controls the Loss of AMPA Receptors and Cognitive Impairment Induced by Repeated Stress. J Neurosci 36:2119-30 (2016). PubMed: 26888924
  • Wang Y  et al. Histone deacetylase enzyme silencing using shRNAs enhances radiosensitivity of SW579 thyroid cancer cells. Mol Med Rep 14:3509-16 (2016). WB ; Human . PubMed: 27600599
  • Sánchez de Diego A  et al. Dido3-dependent HDAC6 targeting controls cilium size. Nat Commun 5:3500 (2014). WB ; Mouse . PubMed: 24667272
  • Wei LH  et al. Histone deacetylase 6 regulates estrogen receptor alpha in uterine leiomyoma. Reprod Sci 18:755-62 (2011). PubMed: 21421902
  • Chen S  et al. HDAC6 regulates mitochondrial transport in hippocampal neurons. PLoS One 5:e10848 (2010). PubMed: 20520769
  • Gloghini A  et al. Expression of histone deacetylases in lymphoma: implication for the development of selective inhibitors. Br J Haematol 147:515-25 (2009). PubMed: 19775297
  • Marquard L  et al. Histone deacetylase 1, 2, 6 and acetylated histone H4 in B- and T-cell lymphomas. Histopathology 54:688-98 (2009). IHC-P ; Human . PubMed: 19438744
  • Munster P  et al. Clinical and biological effects of valproic acid as a histone deacetylase inhibitor on tumor and surrogate tissues: phase I/II trial of valproic acid and epirubicin/FEC. Clin Cancer Res 15:2488-96 (2009). WB ; Human . PubMed: 19318486
  • Marquard L  et al. Prognostic significance of the therapeutic targets histone deacetylase 1, 2, 6 and acetylated histone H4 in cutaneous T-cell lymphoma. Histopathology 53:267-77 (2008). IHC-P ; Human . PubMed: 18671804
  • Yang SH & Sharrocks AD PIASx acts as an Elk-1 coactivator by facilitating derepression. EMBO J 24:2161-71 (2005). PubMed: 15920481


Sign up